Apex Healthcare Berhad Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Apex Healthcare Berhad yıllık ortalama 45.2% oranında kazançlarını artırırken, Pharmaceuticals sektöründe kazançlar growing at 11.6% annual. Gelirler growing yılda ortalama 8.2% oranında artmaktadır. Apex Healthcare Berhad'in özkaynak karlılığı 11% ve net marjı 9.3%'dir.

Anahtar bilgiler

45.2%

Kazanç büyüme oranı

45.0%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi	7.7%
Gelir büyüme oranı	8.2%
Özkaynak getirisi	11.0%
Net Marj	9.3%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

May 08

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Aug 28

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apr 19

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Feb 25

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Aug 24

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

May 11

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

Feb 11

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Jan 25

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Jan 07

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Dec 20

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

Dec 05

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Nov 20

Gelir ve Gider Dağılımı

Apex Healthcare Berhad nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

KLSE:AHEALTH Gelir, gider ve kazançlar (MYR Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	962	89	128
31 Mar 24	939	395	126
31 Dec 23	936	398	124
30 Sep 23	917	413	122
30 Jun 23	913	415	118
31 Mar 23	908	109	116
31 Dec 22	878	101	112
30 Sep 22	855	87	108
30 Jun 22	834	74	107
31 Mar 22	807	63	102
31 Dec 21	771	59	98
30 Sep 21	735	53	94
30 Jun 21	693	53	87
31 Mar 21	685	54	90
31 Dec 20	699	56	93
30 Sep 20	708	56	97
30 Jun 20	719	56	101
31 Mar 20	704	56	100
31 Dec 19	689	53	99
30 Sep 19	681	56	98
30 Jun 19	666	56	97
31 Mar 19	662	57	97
31 Dec 18	653	59	97
30 Sep 18	642	55	96
30 Jun 18	635	51	95
31 Mar 18	634	48	94
31 Dec 17	620	44	90
30 Sep 17	612	38	89
30 Jun 17	597	36	87
31 Mar 17	588	35	86
31 Dec 16	581	35	85
30 Sep 16	571	42	84
30 Jun 16	557	39	82
31 Mar 16	534	36	79
31 Dec 15	527	34	79
30 Sep 15	516	30	78
30 Jun 15	510	32	77
31 Mar 15	508	33	76
31 Dec 14	499	34	75
30 Sep 14	482	32	74
30 Jun 14	461	31	71
31 Mar 14	443	30	69
31 Dec 13	418	30	66

Kaliteli Kazançlar: AHEALTH yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: AHEALTH 'nin mevcut net kar marjları (9.3%) geçen yılın (45.5%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: AHEALTH şirketinin kazançları son 5 yılda yılda 45.2% oranında önemli ölçüde arttı.

Büyüme Hızlandırma: AHEALTH 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: AHEALTH geçtiğimiz yıl negatif kazanç büyümesine ( -78.6% ) sahipti ve bu da onu Pharmaceuticals sektör ortalamasıyla ( -13.3% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: AHEALTH 'nin Özsermaye Getirisi ( 11% ) düşük olarak değerlendiriliyor.

Apex Healthcare Berhad Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Full year 2023 earnings: EPS exceeds analyst expectations

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Recent updates

First half dividend increased to RM0.03

Second quarter 2024 earnings released: EPS: RM0.033 (vs RM0.46 in 2Q 2023)

Apex Healthcare Berhad Announces Interim Single-Tier Dividend for the Financial Year Ending 31 December 2024, Payable on September 18, 2024

Apex Healthcare Berhad Appoint Le Wat Su as Independent and Non Executive Member of Nomination Committee

First quarter 2024 earnings released: EPS: RM0.03 (vs RM0.034 in 1Q 2023)

Apex Healthcare Berhad Approves Special Dividend for the Financial Year Ended December 31, 2023

Why We Think Shareholders May Be Considering Bumping Up Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Compensation

Upcoming dividend of RM0.23 per share

Full year 2023 earnings: EPS exceeds analyst expectations

Apex Healthcare Berhad, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: RM0.56 (vs RM0.14 in FY 2022)

Apex Healthcare Berhad Announces A Special Dividend of the Financial Year Ended 31 December 2023

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Apex Healthcare Berhad Announces Promotion of Miss Chiew Woon Wui from Financial Controller to Chief Financial Officer, Effective on January 1, 2024

Third quarter 2023 earnings released: EPS: RM0.034 (vs RM0.038 in 3Q 2022)

Upcoming dividend of RM0.025 per share at 2.5% yield

Price target decreased by 7.3% to RM2.55

Apex Healthcare Berhad (KLSE:AHEALTH) Will Pay A Dividend Of MYR0.025

Apex Healthcare Berhad Provides Earnings Guidance for the Year 2023

Price target decreased by 7.8% to RM2.58

Second quarter 2023 earnings released: EPS: RM0.46 (vs RM0.033 in 2Q 2022)

Investor sentiment deteriorates as stock falls 36%

First quarter 2023 earnings released: EPS: RM0.051 (vs RM0.033 in 1Q 2022)

Upcoming dividend of RM0.055 per share at 2.3% yield

Apex Healthcare Berhad Appoints Yap Seng Chong as Independent and Non-Executive Chairman of Audit Committee, Date of Change 18 May 2023

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improves as stock rises 15%

Full year 2022 earnings released: EPS: RM0.21 (vs RM0.13 in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.057 (vs RM0.03 in 3Q 2021)

Insufficient new directors

Upcoming dividend of RM0.03 per share

Second quarter 2022 earnings released: EPS: RM0.05 (vs RM0.027 in 2Q 2021)

Apex Healthcare Berhad Declares an Interim Dividend, Payable on 15 September 2022

Price target increased to RM3.21

Upcoming dividend of RM0.09 per share

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target increased to RM3.07

Insufficient new directors

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Apex Healthcare Berhad (KLSE:AHEALTH) Has Announced That It Will Be Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Proposes Special Single-Tier Dividend for Financial Year Ended 31 December 2021, Payable on 16 June 2022

Apex Healthcare Berhad (KLSE:AHEALTH) Is Increasing Its Dividend To RM0.09

Apex Healthcare Berhad Announces Special Dividend in Respect of the Financial Year Ended 31 December2021, Payable on 16 June 2022

Full year 2021 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Third quarter 2021 earnings released: EPS RM0.03 (vs RM0.03 in 3Q 2020)

Upcoming dividend of RM0.025 per share

Apex Healthcare Berhad (KLSE:AHEALTH) Is Paying Out A Larger Dividend Than Last Year

Second quarter 2021 earnings released: EPS RM0.027 (vs RM0.028 in 2Q 2020)

Upcoming dividend of RM0.028 per share

First quarter 2021 earnings released: EPS RM0.025 (vs RM0.03 in 1Q 2020)

Here's Why Apex Healthcare Berhad (KLSE:AHEALTH) Can Manage Its Debt Responsibly

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Is Apex Healthcare Berhad (KLSE:AHEALTH) A Smart Pick For Income Investors?

Estimating The Intrinsic Value Of Apex Healthcare Berhad (KLSE:AHEALTH)

Does Apex Healthcare Berhad (KLSE:AHEALTH) Deserve A Spot On Your Watchlist?

Full year 2020 earnings released: EPS RM0.12 (vs RM0.11 in FY 2019)

Revenue and earnings miss expectations

New 90-day low: RM3.32

Will Weakness in Apex Healthcare Berhad's (KLSE:AHEALTH) Stock Prove Temporary Given Strong Fundamentals?

These 4 Measures Indicate That Apex Healthcare Berhad (KLSE:AHEALTH) Is Using Debt Reasonably Well

Why Apex Healthcare Berhad (KLSE:AHEALTH) Should Be In Your Dividend Portfolio

Do Insiders Own Lots Of Shares In Apex Healthcare Berhad (KLSE:AHEALTH)?

Apex Healthcare Berhad (KLSE:AHEALTH) Has Rewarded Shareholders With An Exceptional 354% Total Return On Their Investment

New 90-day high: RM3.78

Apex Healthcare Berhad to Be Deleted from Other OTC

Why Apex Healthcare Berhad's (KLSE:AHEALTH) CEO Pay Matters

Third quarter 2020 earnings released: EPS RM0.03

Upcoming Dividend of RM0.017 Per Share